Post 2
-
Special forum features advice about how to best communicate vaccine safety and efficacy
AACR Immediate Past President Antoni Ribas, MD, PhD, FAACR, and Gilbert S. Omenn, MD, PhD, moderated a panel focused on COVID-19 vaccine confidence.
-
Presenters examine advances in nanomedicine and evolving drug delivery approaches
(Clockwise, from top left) Daniel A. Heller, PhD, Philip S. Low, PhD, Puja Sapra, PhD, and Darrell J. Irvine, PhD, took part in the session and related panel discussion.
-
Week 2 of the virtual AACR Annual Meeting starts May 17
Continuing through May 21, Week 2 will feature a robust program featuring educational sessions, methods workshops, meet-the-expert sessions, science policy sessions, and professional advancement sessions.
-
Symposium explores role of radiomics, AI analysis in cancer imaging
(From left) Maryellen L. Giger, PhD, Eugene Jon Koay, MD, PhD, and Robert J. Gillies, PhD, also took part in a panel discussion during the AACR Annual Meeting 2021.
-
Session highlights transcriptional CDKs as cancer target
The presentation featured (from left) Ricky W. Johnstone, PhD, Rani George, MD, PhD, and Ali Shilatifard, PhD.
-
Session examines mechanisms and myths of radiation-induced cancer
(From left) Jean L. Nakamura, MD, and Jason Harris, PhD, gave presentations and participated in a panel discussion.
-
Symposium discusses precision medicine approaches for familial cancers
(From left) Yael P. Mossé, MD, Susan M. Domchek, MD, Uri Tabori, MD, David Malkin, MD, spoke during the symposium and related panel discussion.
-
Symposium focuses on novel genomic approaches to studying diffuse large B-cell lymphoma
(From left) Ari Melnick, MD, Margaret A. Shipp, MD, and Michael R. Green, PhD, shared their findings during their presentation.